Due to the wide influences of DUSP22 on MAPKs activation, inflammation- and fibrosis-associated diseases or responses, we hypothesized that there may be a potential functional involvement of DUSP22 in NASH pathogenesis and associated HCC. Here, DUSP22 is linked to hepatocellular carcinoma.